Copyright Reports & Markets. All rights reserved.

Global ED Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of ED Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global ED Treatment Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Sildenafil
    • 1.3.3 Tadalafil
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global ED Treatment Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Drugstores
    • 1.4.4 Other
  • 1.5 Global ED Treatment Market Size & Forecast
    • 1.5.1 Global ED Treatment Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global ED Treatment Sales Quantity (2019-2030)
    • 1.5.3 Global ED Treatment Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Eli Lilly
    • 2.1.1 Eli Lilly Details
    • 2.1.2 Eli Lilly Major Business
    • 2.1.3 Eli Lilly ED Treatment Product and Services
    • 2.1.4 Eli Lilly ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Eli Lilly Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer ED Treatment Product and Services
    • 2.2.4 Pfizer ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 Bayer
    • 2.3.1 Bayer Details
    • 2.3.2 Bayer Major Business
    • 2.3.3 Bayer ED Treatment Product and Services
    • 2.3.4 Bayer ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bayer Recent Developments/Updates
  • 2.4 BaiYunShan General Factory
    • 2.4.1 BaiYunShan General Factory Details
    • 2.4.2 BaiYunShan General Factory Major Business
    • 2.4.3 BaiYunShan General Factory ED Treatment Product and Services
    • 2.4.4 BaiYunShan General Factory ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 BaiYunShan General Factory Recent Developments/Updates
  • 2.5 S.K. Chemicals
    • 2.5.1 S.K. Chemicals Details
    • 2.5.2 S.K. Chemicals Major Business
    • 2.5.3 S.K. Chemicals ED Treatment Product and Services
    • 2.5.4 S.K. Chemicals ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 S.K. Chemicals Recent Developments/Updates
  • 2.6 Teva Pharma
    • 2.6.1 Teva Pharma Details
    • 2.6.2 Teva Pharma Major Business
    • 2.6.3 Teva Pharma ED Treatment Product and Services
    • 2.6.4 Teva Pharma ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Teva Pharma Recent Developments/Updates
  • 2.7 Dong-A ST
    • 2.7.1 Dong-A ST Details
    • 2.7.2 Dong-A ST Major Business
    • 2.7.3 Dong-A ST ED Treatment Product and Services
    • 2.7.4 Dong-A ST ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Dong-A ST Recent Developments/Updates
  • 2.8 Metuchen Pharma
    • 2.8.1 Metuchen Pharma Details
    • 2.8.2 Metuchen Pharma Major Business
    • 2.8.3 Metuchen Pharma ED Treatment Product and Services
    • 2.8.4 Metuchen Pharma ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Metuchen Pharma Recent Developments/Updates
  • 2.9 Seoul Pharma
    • 2.9.1 Seoul Pharma Details
    • 2.9.2 Seoul Pharma Major Business
    • 2.9.3 Seoul Pharma ED Treatment Product and Services
    • 2.9.4 Seoul Pharma ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Seoul Pharma Recent Developments/Updates
  • 2.10 CSBIO.
    • 2.10.1 CSBIO. Details
    • 2.10.2 CSBIO. Major Business
    • 2.10.3 CSBIO. ED Treatment Product and Services
    • 2.10.4 CSBIO. ED Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 CSBIO. Recent Developments/Updates

3 Competitive Environment: ED Treatment by Manufacturer

  • 3.1 Global ED Treatment Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global ED Treatment Revenue by Manufacturer (2019-2024)
  • 3.3 Global ED Treatment Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of ED Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 ED Treatment Manufacturer Market Share in 2023
    • 3.4.2 Top 6 ED Treatment Manufacturer Market Share in 2023
  • 3.5 ED Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 ED Treatment Market: Region Footprint
    • 3.5.2 ED Treatment Market: Company Product Type Footprint
    • 3.5.3 ED Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global ED Treatment Market Size by Region
    • 4.1.1 Global ED Treatment Sales Quantity by Region (2019-2030)
    • 4.1.2 Global ED Treatment Consumption Value by Region (2019-2030)
    • 4.1.3 Global ED Treatment Average Price by Region (2019-2030)
  • 4.2 North America ED Treatment Consumption Value (2019-2030)
  • 4.3 Europe ED Treatment Consumption Value (2019-2030)
  • 4.4 Asia-Pacific ED Treatment Consumption Value (2019-2030)
  • 4.5 South America ED Treatment Consumption Value (2019-2030)
  • 4.6 Middle East and Africa ED Treatment Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global ED Treatment Sales Quantity by Type (2019-2030)
  • 5.2 Global ED Treatment Consumption Value by Type (2019-2030)
  • 5.3 Global ED Treatment Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global ED Treatment Sales Quantity by Application (2019-2030)
  • 6.2 Global ED Treatment Consumption Value by Application (2019-2030)
  • 6.3 Global ED Treatment Average Price by Application (2019-2030)

7 North America

  • 7.1 North America ED Treatment Sales Quantity by Type (2019-2030)
  • 7.2 North America ED Treatment Sales Quantity by Application (2019-2030)
  • 7.3 North America ED Treatment Market Size by Country
    • 7.3.1 North America ED Treatment Sales Quantity by Country (2019-2030)
    • 7.3.2 North America ED Treatment Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe ED Treatment Sales Quantity by Type (2019-2030)
  • 8.2 Europe ED Treatment Sales Quantity by Application (2019-2030)
  • 8.3 Europe ED Treatment Market Size by Country
    • 8.3.1 Europe ED Treatment Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe ED Treatment Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific ED Treatment Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific ED Treatment Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific ED Treatment Market Size by Region
    • 9.3.1 Asia-Pacific ED Treatment Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific ED Treatment Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America ED Treatment Sales Quantity by Type (2019-2030)
  • 10.2 South America ED Treatment Sales Quantity by Application (2019-2030)
  • 10.3 South America ED Treatment Market Size by Country
    • 10.3.1 South America ED Treatment Sales Quantity by Country (2019-2030)
    • 10.3.2 South America ED Treatment Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa ED Treatment Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa ED Treatment Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa ED Treatment Market Size by Country
    • 11.3.1 Middle East & Africa ED Treatment Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa ED Treatment Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 ED Treatment Market Drivers
  • 12.2 ED Treatment Market Restraints
  • 12.3 ED Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of ED Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of ED Treatment
  • 13.3 ED Treatment Production Process
  • 13.4 ED Treatment Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 ED Treatment Typical Distributors
  • 14.3 ED Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global ED Treatment market size was valued at USD 5026.4 million in 2023 and is forecast to a readjusted size of USD 7430 million by 2030 with a CAGR of 5.7% during review period.
    Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the ED Treatment industry chain, the market status of Hospitals (Sildenafil, Tadalafil), Drugstores (Sildenafil, Tadalafil), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of ED Treatment.
    Regionally, the report analyzes the ED Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global ED Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the ED Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the ED Treatment industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Sildenafil, Tadalafil).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the ED Treatment market.
    Regional Analysis: The report involves examining the ED Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the ED Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to ED Treatment:
    Company Analysis: Report covers individual ED Treatment manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards ED Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Drugstores).
    Technology Analysis: Report covers specific technologies relevant to ED Treatment. It assesses the current state, advancements, and potential future developments in ED Treatment areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the ED Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    ED Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Sildenafil
    Tadalafil
    Others
    Market segment by Application
    Hospitals
    Drugstores
    Other
    Major players covered
    Eli Lilly
    Pfizer
    Bayer
    BaiYunShan General Factory
    S.K. Chemicals
    Teva Pharma
    Dong-A ST
    Metuchen Pharma
    Seoul Pharma
    CSBIO.
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe ED Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of ED Treatment, with price, sales, revenue and global market share of ED Treatment from 2019 to 2024.
    Chapter 3, the ED Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the ED Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and ED Treatment market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of ED Treatment.
    Chapter 14 and 15, to describe ED Treatment sales channel, distributors, customers, research findings and conclusion.

    Buy now